Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial

Xiaowen Bai1, Yasheng Yan, Yao-Hua Song

  • 1Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, SCRB2, Unit 951, 7435 Fannin Street, Houston, TX 77054, USA.

European Heart Journal
|December 29, 2009
PubMed

Insights

Freshly isolated adipose tissue-derived cells (fhADCs) and cultured adipose tissue-derived stem cells (hASCs) both improve cardiac function after myocardial infarction. These cells survive long-term, integrate into heart tissue, and promote myocardial repair.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) leads to significant cardiac damage and functional decline.
  • Adipose tissue-derived cells offer potential for cardiac repair but require comparative analysis.
  • Understanding cell survival, differentiation, and mechanisms is crucial for therapeutic development.

Purpose of the Study:

  • To compare the efficacy of freshly isolated adipose tissue-derived cells (fhADCs) and cultured adipose tissue-derived stem cells (hASCs) in treating myocardial infarction.
  • To evaluate the long-term survival and integration of these cells within the infarcted cardiac tissue.
  • To elucidate whether observed therapeutic effects stem from direct cell differentiation or paracrine signaling.

Main Methods:

  • Myocardial infarction was induced in immunodeficient mice.
  • Mice received injections of fhADCs, hASCs, or a control solution in the peri-infarct region.
  • Cardiac function, cell survival (bioluminescence imaging), differentiation (immunofluorescence), vascularization, and apoptosis were assessed.

Main Results:

  • Both fhADCs and hASCs significantly improved cardiac function 4 weeks post-MI.
  • Injected cells expressed cardiomyogenic markers (connexin 43, troponin I) and integrated into host tissue and vasculature.
  • Cells survived up to 4 months, with increased vascular density and reduced apoptosis in treated hearts.

Conclusions:

  • This study provides the first systematic comparison of fhADCs and hASCs for myocardial regeneration.
  • Both fhADCs and hASCs demonstrate engraftment, long-term survival, and functional improvement in infarcted hearts.
  • fhADCs represent a promising alternative cell source for myocardial repair, similar to hASCs.
Abstract

Related Concept Videos